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Purpose
Doppler testing is a well standardized method for an accurate diagnosis of significant
Renal Artery Stenoses (RAS); little experimental data is available on the ability of US
techniques in evaluating side differences in the renal kinetics of a contrast agent in
RAS. The purpose of the study was to compare the contrast enhancement ultrasound
(CEU) technique with renal scintigraphy in detecting renal hemodynamic asymmetry in
renovascular hypertensives.
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Fig. 1: Color and doppler velocity characterization of an hemodynamic stenosis of the
left renal artery.
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Methods and Materials
13 hypertensive patients (54 to 88 years; mean 74 + 10) with significant (>60%) RAS
(Doppler examination, renal angioCT) underwent renal CEU ("wash-in/wash-out" curve
analysis of an iv 2,5 ml sulphur hexafluoride bolus injection followed by 5 ml saline
solution) and Sequential Renal Scintigraphy (SRS) with Captopril test. The sulphur
hexafluoride renal kinetic was calculated by measuring the following parameters: Time to
Peak (TTP), Regional Blood Volume (RBV), Regional Blood Flow (RBF), Mean Transit
Time (MTT) and percentage of contrast intensity to peak (PEAK SI). Effective renal
plasma flow (ERPF) was computed by Hippuran clearance and glomerular filtration rate
(GFR) by DTPA clearance using an uptake method and proprietary program validated at
our institution. The method is based on time-activity curves measured on the heart and
kidney areas by the region-of-interest technique. Mean parenchymal transit time (MPTT)
was calculated for each kidney by deconvolution analysis, using ROI technique by mean
a proprietary software running under Windows MatLab 6.1.The time-activity curve from
a precordial ROI over the left ventricle is used as the input function and the activity-time
curve from renal parenchymal ROI, excluding calyceal and pelvic regions, is used for
deconvolution analysis by matrix algorithm method according to Britton.
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Fig. 1: The red dashed line outlines the area analyzed by the software on a pixel by
pixel basis.
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Fig. 2: Renal parenchyma appearance following contrast adiministration.
Fig. 3: Normal renal kinetics of the contrast agent.
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Results
In all patients, at SRS examination, the renal plasma flow of the affected kidney was
signficantly lower than in the contralateral one (p<0.01). The glomerular filtration rate
showed a significant reduction after Captopril administration only in the affected kidney
(p<0.01), consistent with significant ipsilateral renin activation. In all patients, at CEU
examination, the TTP values of the affected kidney were significantly greater than in the
contralateral one (p<0.01). No significant differences were found in MTT, RBF and RBV
between the two sides.
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Fig. 1: Perfusion curves of the two kidneys were compared by "Q-Compare" analysis.
Note the steep upslope of the curve in the normal kidney (right bottom panel)and the
delayed peaking of the curve of the stenostic kidney (left bottom panel).
Fig. 2: Perfusion parameters PEAK:maximum signal intensity reached during the transit
of the contrast bolus; TTP: Time-To-Peak, time of arrival of the contrast agent to its
maximum signal intensity value; RBV: regional blood volume (proportional to the area
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under the curve - A.U.C.); RBF: regional blood flow (i.e. RBV/MTT); MTT: mean transit
time (circulation time of the contrast agent in the investigated renal parenchyma).
Fig. 3: BASELINE ERPF: Baseline Hippuran clearance. CAPTOPRIL HIPPURAN:
Hippuran clearance after Captopril administration. BASELINE GFR: Baseline DTPA
clearance. CAPTOPRIL DTPA: DTPA clearance after Captopril administration.
BASELINE MPTT: Baseline Mean Parenchymal Transit Time. ACE MPTT: Mean
Parenchymal Transit Time after Captopril administration.
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Conclusion
An increase in TTP at CEU examination can reveal a defect in cortical perfusion of the
kidney with significant RAS. The finding is consistent with the hemodynamic scintigraphic
results; compared to Doppler velocity and resistive indices alone, the application of CEU
can provide additional perfusion data that can be considered in therapeutic decisions.
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